anonymous
Guest
anonymous
Guest
Bayer lies! That’s what they do well.
The VM product is still too far out, Astellas has a competitor and there is a 3rd hormonal one coming too, without the CV risk.
Lying to Wall Street or to the field? Hmmm
Reorg is coming!
The VM product is still too far out, Astellas has a competitor and there is a 3rd hormonal one coming too, without the CV risk.
Lying to Wall Street or to the field? Hmmm
Reorg is coming!